Gapping up
In reaction to strong earnings/guidance: RH +16.1%, SIGM +11.7%, DDC +10.1%.
Select oil/gas related names showing strength: PBR +1.5%, HK +1.2%, EOG +1.1%, RDS.A +1%, SD +0.9%, SDRL +0.8%, BP +0.7%, XOM +0.7%, MRO +0.7%.
Other news: ZLCS +51.9% (Epirus Biopharmaceuticals announced positive data from a Phase 3 trial of BOW015 in patients with active rheumatoid arthritis; ZLCS entered into an agreement and plan of merger with Epirus on April 15), GERN +35.4% (reports removal of partial clinical hold on Myelofibrosis IST), PVCT +11.4% (to discuss outline of Phase 3 clinical trial of PV-10 to treat melanoma on conference call on June 19), KEYW +9.3% (U.S. Government Agency Selects HawkEye G for Advanced Threat Detection), TIBX +6.1% (Praesidium issues letter to TIBCO's Board of Directors; reports ownership of approx. 5.5 mln shares), MSLI +5.5% (announces $22.1 mln bought deal financing; Underwriters to purchase 13 mln common shares ), ARNA +4.4% (continued strength following exec on Fast Money), GTAT +2.7% (seeing continued strength (+6.5% yesterday)), FNSR +2.3% (earnings expected later today), BCR +2.2% (announces $500 mln share repurchase authorization, increases quarterly dividend ), SPEX +2.1% (commences litigation against Verizon (VZ) for patent infringement), CNX +2.1% (announces plans to form a Midstream Master Limited Partnership with CNX), BBRY +2.1% (announced new three-year agreement with EnStream), PLG +1.7% (reports the Waterberg Resource increases significantly to 29 mln ounces 4E-Platinum, Palladium, Rhodium and Gold), JD +1.6% (still checking), NQ(E) +1.6% (cont vol from yesterday), TSLA +0.9% (patent related announcement confirmed for Friday, according to Elon Musk tweet) NBL +0.8% (announces plans to form a Midstream Master Limited Partnership with Noble Energy (NBL)).
Analyst comments: SNSS +8.5% (initiated with a Buy and $14 tgt at UBS), HALO +3.3% (upgraded to Buy from Neutral at UBS), ACHN +1.6% (upgraded to Buy from Neutral at UBS), HPQ +1.2% (upgraded to Neutral from Sell at Goldman), SAM +0.5% (upgraded to Outperform from Underperform at Credit Agricole)
In reaction to strong earnings/guidance: RH +16.1%, SIGM +11.7%, DDC +10.1%.
Select oil/gas related names showing strength: PBR +1.5%, HK +1.2%, EOG +1.1%, RDS.A +1%, SD +0.9%, SDRL +0.8%, BP +0.7%, XOM +0.7%, MRO +0.7%.
Other news: ZLCS +51.9% (Epirus Biopharmaceuticals announced positive data from a Phase 3 trial of BOW015 in patients with active rheumatoid arthritis; ZLCS entered into an agreement and plan of merger with Epirus on April 15), GERN +35.4% (reports removal of partial clinical hold on Myelofibrosis IST), PVCT +11.4% (to discuss outline of Phase 3 clinical trial of PV-10 to treat melanoma on conference call on June 19), KEYW +9.3% (U.S. Government Agency Selects HawkEye G for Advanced Threat Detection), TIBX +6.1% (Praesidium issues letter to TIBCO's Board of Directors; reports ownership of approx. 5.5 mln shares), MSLI +5.5% (announces $22.1 mln bought deal financing; Underwriters to purchase 13 mln common shares ), ARNA +4.4% (continued strength following exec on Fast Money), GTAT +2.7% (seeing continued strength (+6.5% yesterday)), FNSR +2.3% (earnings expected later today), BCR +2.2% (announces $500 mln share repurchase authorization, increases quarterly dividend ), SPEX +2.1% (commences litigation against Verizon (VZ) for patent infringement), CNX +2.1% (announces plans to form a Midstream Master Limited Partnership with CNX), BBRY +2.1% (announced new three-year agreement with EnStream), PLG +1.7% (reports the Waterberg Resource increases significantly to 29 mln ounces 4E-Platinum, Palladium, Rhodium and Gold), JD +1.6% (still checking), NQ(E) +1.6% (cont vol from yesterday), TSLA +0.9% (patent related announcement confirmed for Friday, according to Elon Musk tweet) NBL +0.8% (announces plans to form a Midstream Master Limited Partnership with Noble Energy (NBL)).
Analyst comments: SNSS +8.5% (initiated with a Buy and $14 tgt at UBS), HALO +3.3% (upgraded to Buy from Neutral at UBS), ACHN +1.6% (upgraded to Buy from Neutral at UBS), HPQ +1.2% (upgraded to Neutral from Sell at Goldman), SAM +0.5% (upgraded to Outperform from Underperform at Credit Agricole)